Advisory Committee on the Medical Uses of Isotopes: Call for Nominations

Issuing agencies

Abstract

The U.S. Nuclear Regulatory Commission (NRC) is soliciting nominations for the position of Nuclear Pharmacist on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a currently practicing nuclear pharmacist.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 206 (Tuesday, October 27, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 206 (Tuesday, October 27, 2026)]
[Notices]
[Pages 67622-67623]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21881]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting 
nominations for the position of Nuclear Pharmacist on the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a 
currently practicing nuclear pharmacist.

DATES: Nominations are due on or before December 28, 2026.

FOR FURTHER INFORMATION CONTACT: Sarah Hoenig, U.S. Nuclear Regulatory 
Commission, Office of Nuclear Material Safety and Safeguards; 301-415-
3284; <a href="/cdn-cgi/l/email-protection#e6b58794878ec8ae8983888f81a6889485c8818990"><span class="__cf_email__" data-cfemail="e1b280938089cfa98e848f8886a18f9382cf868e97">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Nomination Process: Submit an electronic 
copy of resume or curriculum vitae, along with a cover letter, to Ms. 
Sarah Hoenig, <a href="/cdn-cgi/l/email-protection#65360417040d4b2d0a000b0c02250b17064b020a13"><span class="__cf_email__" data-cfemail="a0f3c1d2c1c88ee8cfc5cec9c7e0ced2c38ec7cfd6">[email&#160;protected]</span></a>. The cover letter should describe 
the nominee's current duties and responsibilities and express the 
nominee's interest in the position. Please ensure that the resume or 
curriculum vitae includes the following information, if applicable: 
education; certification(s); professional association and committee 
membership activities; duties and responsibilities in current and 
previous clinical, research, and/or academic position(s).
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) nuclear medicine physician; (b) nuclear 
cardiologist; (c) two radiation oncologists; (d) diagnostic 
radiologist; (e) therapy medical physicist; (f) nuclear medicine 
physicist; (g) nuclear pharmacist; (h) radiation safety officer; (i) 
patients' rights advocate; (j) Food and Drug Administration 
representative; (k) Agreement State representative; and (l) 
interventional radiologist (vacant). For additional information about 
membership on the ACMUI, visit the ACMUI Membership web page, <a href="http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html">http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html</a>.
    The ACMUI Nuclear Pharmacist provides advice on issues associated 
with the regulation of nuclear pharmacy applications of byproduct 
material. This advice includes providing input on NRC proposed rules 
and guidance, providing recommendations on the training and experience 
requirements for Authorized Nuclear Pharmacists, identifying medical 
events associated with these uses, evaluating non-routine uses of 
byproduct material, bringing key issues in the nuclear pharmacy 
community to the attention of NRC staff, as they relate to 
radiopharmaceuticals, radiation safety and NRC medical-use policy. This 
individual is appointed based on his or her educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to ACMUI business. Members are expected to attend 
semi-annual full-day virtual meetings and to participate in other 
shorter teleconferences or virtual meetings, as needed. ACMUI members 
who present during the annual ACMUI Commission Briefing Meeting, may 
need to travel to attend these meetings in-person at NRC HQs in 
Rockville, MD. Committee members currently serve a four-year term and 
may be considered for reappointment to an additional term.
    Members who are not Federal employees at the time of their 
appointment are compensated for their service. In addition, members are

[[Page 67623]]

reimbursed for travel (including per diem in lieu of subsistence) and 
are reimbursed secretarial and correspondence expenses. Full-time 
Federal employees are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland this 23 of October 2026.

    For the U.S. Nuclear Regulatory Commission.
Tomas E. Herrera,
Deputy Secretary of the Commission.
[FR Doc. 2026-21881 Filed 10-26-26; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>